Natixis Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.57M | Buy |
|
|||||
|
2025
Q1 | $3.68M | Sell |
|
|||||
|
2024
Q4 | $4.59M | Buy |
|
|||||
|
2024
Q3 | $3.38M | Sell |
|
|||||
|
2024
Q2 | $4.85M | Buy |
|
|||||
|
2024
Q1 | $4.38M | Buy |
|
|||||
|
2023
Q4 | $3.93M | Sell |
|
|||||
|
2023
Q3 | $3.41M | Buy |
|
|||||
|
2023
Q2 | $2.34M | Sell |
|
|||||
|
2023
Q1 | $5.49M | Sell |
|
|||||
|
2022
Q4 | $7.31M | Sell |
|
|||||
|
2022
Q3 | $7.48M | Buy |
|
|||||
|
2022
Q2 | $6.51M | Buy |
|
|||||
|
2022
Q1 | $5.66M | Buy |
|
|||||
|
2021
Q4 | $2.35M | Sell |
|
|||||
|
2021
Q3 | $3.93M | Buy |
|
|||||
|
2021
Q2 | $3.42M | Buy |
|
|||||
|
2021
Q1 | $3.31M | Buy |
|
|||||
|
2020
Q4 | $2.91M | Sell |
|
|||||
|
2020
Q3 | $3.27M | Buy |
|
|||||
|
2020
Q2 | $1.83M | Buy |
|
|||||
|
2020
Q1 | $1.26M | Buy |
|
|||||
|
2019
Q4 | $1.26M | Buy |
|
|||||
|
2019
Q3 | $957K | Buy |
|